AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Cash Flow from Investing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹13 Cr | ₹-5.30 Cr | ₹-17 Cr | ₹5.08 Cr | ₹10 Cr |
What is the latest Cash Flow from Investing Activities ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹-5.30 Cr |
| Mar2023 | ₹-17 Cr |
| Mar2022 | ₹5.08 Cr |
| Mar2021 | ₹10 Cr |
How is Cash Flow from Investing Activities of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | Positive | |
| Mar2024 | ₹-5.30 Cr | Negative | |
| Mar2023 | ₹-17 Cr | Negative | |
| Mar2022 | ₹5.08 Cr | -49.68 | |
| Mar2021 | ₹10 Cr | - | |
Compare Cash Flow from Investing Activities of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹209.1 Cr | 4.8% | 3% | -44.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,062.0 Cr | 0.4% | 2.6% | NA | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,192.0 Cr | -4.5% | 0.7% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,129.0 Cr | 5% | 4.1% | 37.2% | Stock Analytics | |
| CIPLA | ₹108,513.0 Cr | -0.5% | -3.4% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,250.0 Cr | 1.2% | 10.2% | 4.8% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | 4.8% |
3% |
-44.2% |
| SENSEX | -1% |
-0.1% |
7.9% |
You may also like the below Video Courses